CENT SYDNEY AREA HEALTH SERV has a total of 32 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Japan, United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are KOCHER THEODOR INST, AMARILLO CELL CULTURE CO and DASSEUX JEAN LOUIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 9 | |
#2 | United States | 9 | |
#3 | Australia | 6 | |
#4 | Canada | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Hong Kong | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Baxter Robert Charles | 14 |
#2 | Anderson Sandra Doreen | 11 |
#3 | Robert Charles Baxter | 1 |
#4 | Baxter Robert C | 1 |
#5 | Anderson Saudra Doreen | 1 |
Publication | Filing date | Title |
---|---|---|
AU2002950360A0 | Method for assessing liver function | |
US6465423B1 | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex | |
AUPO584197A0 | GDNA purification from whole blood or tissue | |
AUPN837696A0 | Treatment of cystic fibrosis | |
AUPM411494A0 | Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum | |
US5324820A | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex | |
CA1341598C | Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex | |
AU3961689A | Acid-labile subunit (als) of insulin-like-growth factor (igf)binding protein complex |